Zacks Investment Research on MSN8h
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease IndicationAmgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...
Espin induces abundant filopodia formation at the leading edge and along the sides, exerting force for cells migrating in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback